{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:26:55Z","timestamp":1761596815351},"reference-count":67,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":4968,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1999,8]]},"abstract":"<jats:p>There is evidence from observational studies that estrogen replacement therapy in postmenopausal women can reduce the rates of morbidity and mortality of atherosclerotic heart disease. The mechanism of this cardiovascular protective effect is not yet established, but favorable actions of hormone therapy on plasma lipids and vascular endothelial function have been proposed. Estrogens can also increase the risk of breast and uterine carcinoma. The new selective estrogen receptor modulator (SERM) raloxifene appears to have benefits similar to estrogen on plasma lipids and osteoporosis, but it does not affect the rate of uterine carcinoma as does tamoxifen and estrogen. Animal studies suggest an anti\u2010atherosclerotic action of raloxifene, but this needs to be confirmed in long\u2010term human studies.<\/jats:p>","DOI":"10.1177\/00912709922008416","type":"journal-article","created":{"date-parts":[[2003,7,19]],"date-time":"2003-07-19T09:38:13Z","timestamp":1058607493000},"page":"767-774","source":"Crossref","is-referenced-by-count":12,"title":["Raloxifene, a New Selective Estrogen Receptor Modulator"],"prefix":"10.1002","volume":"39","author":[{"given":"Deborah","family":"Goldfrank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahir","family":"Haytoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zalt","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199109123251102"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1995.tb04066.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"273","author":"Writing Group for the PEPI Trial","year":"1995","journal-title":"JAMA"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-5-925"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.5_Suppl_7.21S"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.9.688"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(95)00429-7"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90247-3"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506153322401"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116985"},{"issue":"1","key":"e_1_2_1_12_2","first-page":"S118","article-title":"Raloxifene, an \u201cantiestrogen\u201d simulates the effects of estrogen on inhibiting bone resorption through regulating TGF\u03b2\u20103 expression in bone","volume":"8","author":"Yang NN","year":"1993","journal-title":"J Bone Miner Res"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-11-860"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203263261302"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(95)00291-K"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-4-1132"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.1990.tb07454.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01812678"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.11.3191"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392207"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841869209088894"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)22036-2"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(83)90323-5"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199712043372301"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.2.123"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/39645"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.9.6.659"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5279.1222"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404143301508"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.4.1095"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.75.6.1102"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(88)90063-4"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.18.1445"},{"issue":"1","key":"e_1_2_1_34_2","first-page":"I\u20107","article-title":"Raloxifene favorably alters serum lipids in postmenopausal women with cardiovascular risk factors (abstract)","volume":"98","author":"Anderson PW","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"e_1_2_1_35_2","first-page":"I\u20107","article-title":"Effects of raloxifene and hormone replacement therapy on homocysteine and c\u2010reactive protein levels in postmenopausal women","volume":"17","author":"Paul S","year":"1998","journal-title":"Circulation"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.6.1964"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.3.721"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(96)05894-7"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.20.1534"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80302-6"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.6.1542"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(93)90061-8"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1021\/js970097w"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1991.00400090120021"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.6.1970"},{"key":"e_1_2_1_46_2","first-page":"787","volume-title":"Cardiovascular Pharmacotherapeutics","author":"Gomberg\u2010Maitland M","year":"1997"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07113-9"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07114-0"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804303381814"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80138-7"},{"key":"e_1_2_1_51_2","first-page":"887","article-title":"Venous thrombosis as a side effect of tamoxifen treatment","volume":"68","author":"Lipton A","year":"1984","journal-title":"Cancer Treat Rep"},{"issue":"1","key":"e_1_2_1_52_2","first-page":"I\u2010520","article-title":"Raloxifene regulates thrombomodulin and plasminogen activator inhibitor\u20101 in human endothelial cells","volume":"98","author":"Richardson MA","year":"1998","journal-title":"Circulation"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(96)00313-4"},{"key":"e_1_2_1_54_2","first-page":"2a","article-title":"for the MORE Investigators: Raloxifene reduces the risk of breast cancer and may decrease the endometrial cancer in post menopausal women: two year findings from the Multiple Outcome of Raloxifene Evaluation (MORE) Trial (abstract)","volume":"17","author":"Cummings SR","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01771666"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(83)90935-9"},{"key":"e_1_2_1_57_2","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1210\/endo.135.5.7956922","article-title":"Raloxifene preserves bone strength and bone mass in ovarectomized rats","volume":"135","author":"Turner CH","year":"1994","journal-title":"Endocrinology"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.134.5.8156931"},{"key":"e_1_2_1_59_2","first-page":"339","article-title":"Effects of raloxifene hydrochloride on serum markers of bone and lipid metabolism: dose\u2010response relationships (abstract)","volume":"54","author":"Draper MW","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650110615"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.10.3425"},{"key":"e_1_2_1_62_2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"for the HERS Research Group: Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley SB","year":"1998","journal-title":"JAMA"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.7.650"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(97)00078-0"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.18.1483"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.1998.7.1187"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.1999.8.321"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199957050-00001"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1177%2F00912709922008416","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/00912709922008416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T01:49:49Z","timestamp":1695865789000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1177\/00912709922008416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["10.1177\/00912709922008416"],"URL":"https:\/\/doi.org\/10.1177\/00912709922008416","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}